Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546932 | SCV000641269 | benign | Autosomal recessive distal spinal muscular atrophy 2; Amyotrophic lateral sclerosis type 16 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001287959 | SCV001474729 | benign | not specified | 2020-05-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001561644 | SCV001784280 | likely benign | not provided | 2020-11-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367851 | SCV002665703 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001561644 | SCV004157676 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SIGMAR1: BP4, BP7 |
Genome Diagnostics Laboratory, |
RCV001561644 | SCV001807671 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001561644 | SCV001926048 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001561644 | SCV001966545 | likely benign | not provided | no assertion criteria provided | clinical testing |